38 results on '"Tokhanbigli, Samaneh"'
Search Results
2. Global landscape of SARS-CoV-2 mutations and conserved regions
3. SARS‐CoV‐2 Non-structural protein 1(NSP1) mutation virulence and natural selection: Evolutionary trends in the six continents
4. Mutations in SARS-CoV-2 structural proteins: a global analysis
5. Antigenic Potency of LY6E in Stimulating Dendritic Cells to Elicit Tumor-Specific Responses Against Human Colorectal and Gastric Cancer Cell Lines
6. A Simple High Yield Technique for Isolation of Wharton's Jelly-derived Mesenchymal Stem Cell
7. Gene expression profile of immunoregulatory cytokines secreted from bone marrow and adipose derived human mesenchymal stem cells in early and late passages
8. Mutation accumulation of SARS-CoV-2 genome in North America, South America, and Oceania: Analysis of over 6.5 million sequences samples from Global Initiative on Sharing Avian Influenza Data
9. SARS-CoV-2 Non-structural protein 1(NSP1) mutation virulence and natural selection:Evolutionary trends in the six continents
10. Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL‐6 pathway through miR‐124
11. Contribution of natural killer cells in innate immunity against colorectal cancer
12. Comparative analysis and identification of spike mutations in Iranian COVID-19 samples from the first three waves of disease
13. The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosis
14. Combination of pioglitazone and dendritic cell to optimize efficacy of immune cell therapy in CT26 tumor models.
15. Combination of pioglitazone and dendritic cell to optimize efficacy of immune cell therapy in CT26 tumor models
16. SARS-CoV-2 Non-Structural Protein 1(NSP1) Mutation Virulence and Natural Selection: Evolutionary Trends in the Six Continents
17. Mutational insights among the structural proteins of SARS-CoV-2; comprehensive analyses in the six continents
18. The First Geographic Identification by Country of Sustainable Mutations of SARS-COV2 Sequence Samples: Worldwide Natural Selection Trends
19. Mutations in SARS-CoV-2 structural proteins:a global analysis
20. Comparative Analysis and Identification of Spike Mutations in Iranian COVID‑19 Samples from the First Three Waves of Disease.
21. Analysis of Whole-Genome Sequencing of SARS-CoV-2 Reveals Recurrent Mutations among Iranian Patients
22. SARS-CoV-2 NSP3, NSP4 and NSP6 mutations and Epistasis during the pandemic in the world: Evolutionary Trends and Natural Selections in Six Continents
23. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis
24. Mutation Accumulation of SARS-CoV-2 Genome in North America, South America, and Oceania: Analysis of Over 6.5 Million Sequences Samples from Global Initiative on Sharing Avian Influenza Data
25. SARS‐CoV‐2 Non-Structural Protein 1(NSP1) Mutation Virulence and Natural Selection: Evolutionary Trends in the Six Continents
26. The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosis.
27. Immunoregulatory impact of human mesenchymal-conditioned media and mesenchymal derived exosomes on monocytes
28. Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
29. Antigenic Potency of LY6E in Stimulating Dendritic Cells to Elicit Tumor-Specific Responses Against Human Colorectal and Gastric Cancer Cell Lines
30. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis
31. Development of experimental fibrotic liver diseases animal model by Carbon Tetracholoride
32. Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow
33. Exosomes as a novel cell‐free therapeutic approach in gastrointestinal diseases
34. Paracrine signals of mesenchymal stem cells induce epithelial to mesenchymal transition in gastric cancer cells.
35. Exosomes as a novel cell‐free therapeutic approach in gastrointestinal diseases.
36. Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer.
37. SARS-CoV-2 Non-Structural Protein 1(NSP1) Mutation Virulence and Natural Selection: Evolutionary Trends in the Six Continents.
38. The First Geographic Identification by Country of Sustainable Mutations of SARS-COV2 Sequence Samples: Worldwide Natural Selection Trends.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.